Over the past two months, Beckman Coulter has released its Vidiera NsD nucleic sample detection platform and Vidiera NsP nucleic sample preparation platform. The new instruments are key to the firm's emerging efforts in the molecular diagnostics field. The NsD platform is based on Beckman's capillary electrophoresis technology and was launched last month in the US, with an international roll-out planned for next year. The launch of the NsP, which is based on Beckman's primary tube-handling technology and Biomek automation, was announced last week.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.